We are live on ! Find out more
EGI

EAM Global Investors Portfolio holdings

AUM $47.1M
1-Year Est. Return 320.45%
This Fund
S&P 500
This Quarter Est. Return
-7.87%
1 Year Est. Return
+320.45%
3 Year Est. Return
+2,492.23%
5 Year Est. Return
+19,933.92%
10 Year Est. Return
AUM
$171M
AUM Growth
-$79M
Cap. Flow
-$42M
Cap. Flow %
-24.57%
Top 10 Hldgs %
22.31%
Holding
153
New
44
Increased
29
Reduced
27
Closed
52

Top Sells

Rank Stock Value
1
AUDC icon
AudioCodes
AUDC
+$7.45M
2
PRFT
Perficient Inc
PRFT
+$3.57M
3
BOOT icon
Boot Barn
BOOT
+$3.31M
4
FRO icon
Frontline
FRO
+$2.99M
5
CSW
CSW Industrials
CSW
+$2.97M

Sector Composition

Rank Sector Weight
1 Healthcare 40.86%
2 Technology 24.49%
3 Industrials 11.11%
4 Communication Services 4.08%
5 Consumer Staples 2.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VVX icon
51
V2X
VVX
$2.6B
$1.55M 0.91%
37,432
+4,719
+14% +$240K
EGIO
52
DELISTED
Edgio, Inc. Common Stock
EGIO
$1.54M 0.9%
+6,755
New +$1.34M
CEVA icon
53
CEVA Inc
CEVA
$889M
$1.49M 0.87%
+59,766
New +$1.66M
MGNI icon
54
Magnite
MGNI
$3.47B
$1.47M 0.86%
+264,933
New +$2.43M
PCTI
55
DELISTED
PCTEL, Inc. Common Stock
PCTI
$1.47M 0.86%
220,958
+27,851
+14% +$212K
KRMD icon
56
KORU Medical Systems
KRMD
$157M
$1.45M 0.85%
+192,993
New +$1.3M
SEAC
57
DELISTED
Seachange International Inc
SEAC
$1.42M 0.83%
+19,015
New +$1.45M
TRNS icon
58
Transcat
TRNS
$850M
$1.39M 0.81%
52,426
+6,609
+14% +$198K
PFNX
59
DELISTED
Pfenex Inc.
PFNX
$1.37M 0.8%
155,670
-52,940
-25% -$582K
AGYS icon
60
Agilysys
AGYS
$3.02B
$1.36M 0.8%
+81,439
New +$2.23M
ACH
61
Accendra Health
ACH
$107M
$1.35M 0.79%
+147,389
New +$890K
ADVM
62
DELISTED
Adverum Biotechnologies
ADVM
$1.34M 0.79%
+13,763
New +$1.6M
NAT icon
63
Nordic American Tanker
NAT
$1.33B
$1.34M 0.78%
295,760
-820,607
-74% -$2.96M
APRE icon
64
Aprea Therapeutics
APRE
$7.98M
$1.33M 0.78%
+1,914
New +$1.4M
OCUL icon
65
Ocular Therapeutix
OCUL
$2.03B
$1.31M 0.77%
+265,316
New +$1.31M
PRVB
66
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$1.31M 0.77%
+142,223
New +$1.83M
KRYS icon
67
Krystal Biotech
KRYS
$9.81B
$1.3M 0.76%
30,065
-5
-0% -$262
FLGT icon
68
Fulgent Genetics
FLGT
$524M
$1.29M 0.76%
120,232
-3,438
-3% -$47.9K
DHT icon
69
DHT Holdings
DHT
$2.95B
$1.29M 0.75%
168,024
-73,112
-30% -$463K
SPWH icon
70
Sportsman's Warehouse
SPWH
$46.4M
$1.28M 0.75%
208,662
-71,418
-25% -$445K
MODN
71
DELISTED
MODEL N, INC.
MODN
$1.28M 0.75%
57,569
-48,931
-46% -$1.43M
LK
72
DELISTED
Luckin Coffee Inc. American Depositary Shares
LK
$1.27M 0.75%
46,896
-19,301
-29% -$711K
INSG icon
73
Inseego
INSG
$87.7M
$1.25M 0.73%
+20,075
New +$1.45M
OSUR icon
74
OraSure Technologies
OSUR
$276M
$1.22M 0.72%
+113,722
New +$814K
INFN
75
DELISTED
Infinera Corporation Common Stock
INFN
$1.22M 0.71%
230,153
-34,663
-13% -$238K

Similar funds

EAM Global Investors's Q1 2020 Portfolio in Review

As of Q1 2020, EAM Global Investors held 153 positions worth $171M, down 32% from $250M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

EAM Global Investors withdrew a net $42M in Q1 2020, closing 52 positions and reducing 27 holdings. Its most notable exit was AudioCodes, an estimated $7.45M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 29% a quarter earlier, followed by Technology and Industrials.

Against the trend, EAM Global Investors opened a new position in BELLUS Health Inc. worth $5.44M.

  • EAM Global Investors's largest Q1 2020 buy was BELLUS Health Inc.: 544,795 shares worth $5.44M.
  • EAM Global Investors added most to Axsome Therapeutics in Q1 2020, an estimated $851K increase.
  • EAM Global Investors's biggest Q1 2020 reduction was Nordic American Tanker, cutting an estimated $2.96M.
  • EAM Global Investors fully exited AudioCodes in Q1 2020, selling an estimated $7.45M.
  • EAM Global Investors's ten largest holdings make up 22% of its $171M portfolio in Q1 2020.
  • EAM Global Investors opened 44 new positions and closed 52 in Q1 2020.
  • EAM Global Investors's portfolio value fell 32% quarter-over-quarter to $171M.

Based on EAM Global Investors's 13F filing for Q1 2020, filed 13 May 2020.